Literature DB >> 10884286

Leukocyte CD11b expression is not essential for the development of atherosclerosis in mice.

N Kubo1, W A Boisvert, C M Ballantyne, L K Curtiss.   

Abstract

CD11b is an alpha chain of the leukocyte beta(2)-integrin, Mac-1, which mediates binding and extravasation of leukocytes. Because this event is critical in atherosclerosis, we examined the role of CD11b in lesion formation. Atherosclerosis-susceptible, low density lipoprotein receptor-deficient (LDL-R(-/)-) mice were irradiated and repopulated with bone marrow cells from CD11b-deficient (CD11b(-/)-) mice. After 4 weeks, <2% of the peripheral blood leukocytes of the CD11b(-/)- bone marrow-transplanted LDL-R(-/)- mice expressed CD11b, whereas approximately 25% of the CD11b(+/)+ bone marrow-transplanted LDL-R(-/)- mice expressed CD11b. After consuming a high-fat diet for 16 weeks the mean lesion aortic valve area, cholesterol accumulation in the aorta, and the degree of intimal macrophage infiltration were similar in mice reconstituted with either CD11b(+)(/+) or CD11b(-/)- bone marrow cells. The studies confirm that CD11b expression of bone marrow-derived cells does not influence the development of atherosclerosis in hypercholesterolemic LDL-R(-/)- mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884286

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  16 in total

1.  The Upregulation of Integrin αDβ2 (CD11d/CD18) on Inflammatory Macrophages Promotes Macrophage Retention in Vascular Lesions and Development of Atherosclerosis.

Authors:  Moammir H Aziz; Kui Cui; Mitali Das; Kathleen E Brown; Christopher L Ardell; Maria Febbraio; Elzbieta Pluskota; Juying Han; Huaizhu Wu; Christie M Ballantyne; Jonathan D Smith; Martha K Cathcart; Valentin P Yakubenko
Journal:  J Immunol       Date:  2017-05-12       Impact factor: 5.422

2.  PRECISION MEDICINE FOR CARDIOVASCULAR DISEASE PREVENTION: WHERE DO WE STAND IN 2019 WITH A FOCUS ON INFLAMMATION AND LIPIDS?

Authors:  Christie M Ballantyne
Journal:  Trans Am Clin Climatol Assoc       Date:  2020

Review 3.  Integrin signaling in atherosclerosis.

Authors:  Alexandra C Finney; Karen Y Stokes; Christopher B Pattillo; A Wayne Orr
Journal:  Cell Mol Life Sci       Date:  2017-02-28       Impact factor: 9.261

4.  αMβ₂ integrin activation prevents alternative activation of human and murine macrophages and impedes foam cell formation.

Authors:  Valentin P Yakubenko; Ashish Bhattacharjee; Elzbieta Pluskota; Martha K Cathcart
Journal:  Circ Res       Date:  2011-01-20       Impact factor: 17.367

5.  A Genetic Model of Constitutively Active Integrin CD11b/CD18.

Authors:  Laisel Martinez; Xiaobo Li; Gioser Ramos-Echazabal; Hafeez Faridi; Zachary M Zigmond; Nieves Santos Falcon; Diana R Hernandez; Serene A Shehadeh; Omaida C Velazquez; Vineet Gupta; Roberto I Vazquez-Padron
Journal:  J Immunol       Date:  2020-09-16       Impact factor: 5.422

6.  The role of integrin alpha D beta2 (CD11d/CD18) in monocyte/macrophage migration.

Authors:  Valentin P Yakubenko; Nataly Belevych; Daria Mishchuk; Aleksey Schurin; Stephen C-T Lam; Tatiana P Ugarova
Journal:  Exp Cell Res       Date:  2008-06-04       Impact factor: 3.905

7.  Beta2 integrins modulate the initiation and progression of atherosclerosis in low-density lipoprotein receptor knockout mice.

Authors:  Aksam Merched; Katherine Tollefson; Lawrence Chan
Journal:  Cardiovasc Res       Date:  2009-10-20       Impact factor: 10.787

8.  Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia.

Authors:  Huaizhu Wu; R Michael Gower; Hong Wang; Xiao-Yuan Dai Perrard; Ruidong Ma; Daniel C Bullard; Alan R Burns; Antoni Paul; C Wayne Smith; Scott I Simon; Christie M Ballantyne
Journal:  Circulation       Date:  2009-05-11       Impact factor: 29.690

9.  Leukocyte integrin Mac-1 promotes acute cardiac allograft rejection.

Authors:  Koichi Shimizu; Peter Libby; Rica Shubiki; Masashi Sakuma; Yunmei Wang; Kenichi Asano; Richard N Mitchell; Daniel I Simon
Journal:  Circulation       Date:  2008-03-31       Impact factor: 29.690

10.  αMβ2 Is Antiatherogenic in Female but Not Male Mice.

Authors:  Dorota Szpak; Lahoucine Izem; Dmitriy Verbovetskiy; Dmitry A Soloviev; Valentin P Yakubenko; Elzbieta Pluskota
Journal:  J Immunol       Date:  2018-02-19       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.